The Use of Hemorheological and Microcirculatory Parameters in Evaluating the Effect of Treatment in Raynaud's Phenomenon

Abstract

Hemorheological and microcirculatory techniques were used to explore whether these methods could be used to make objective the possibly subjective changes induced by therapeutic intervention. In this study a vasoactive drug, ketanserin, was used in the treatment of patients with primary and secondary Raynaud's phenomenon.

The subjective clinical improvement in the acute situation could be con firmed by an increase in red blood cell velocity in the nailfold capillaries before and after cold provocation. Dynamic capillary microscopy even allowed dis crimination between patients who did and those who did not respond to longer lasting treatment with ketanserin. The hemorheological parameters did not dis tinguish respondents from nonrespondents.

In conclusion, dynamic capillary microscopy can be used to evaluate subjec tive changes of treatment and to distinguish respondents from nonrespondents to treatment.

Get full access to this article

View all access options for this article.

References

Raynaud M. : De l'asphyxie locale et de la gangrène symmétrique des extrémités. Thesis 1862 L Leclerc, Libraire-Editeur, Paris.

Pringle R. , Walder DN , Weaver Jpa : Blood viscosity and Raynaud's disease. Lancet 1:1086, 1965.

Dintenfass L. : Hemorheological factors in Raynaud's phenomenon . Angiology 28:472, 1977.

Dormandy JL : Haemorheological aspects of Raynaud's disease and phenomenon. Adv Microcirc 10:53, 1982.

Goyle KB , Dormandy JA : Abnormal blood viscosity in Raynaud's phenomenon. Lancet 1:1317, 1976.

Jacobs Mjhm , Slaaf DW , Reneman RS , et al: Red blood cell velocity in the nailfold capillary and haemorheological changes in patients with ischaemic hand phenomena. Int J Microcirc: Clin Exp 3(3/4):457, 1984.

Harper FF , Maricq HR , Turner RF , et al: A prospective study of Raynaud's phenomenon and early connective tissue disease. A five year report. Am J Med 72(6):883, 1982.

Bollinger A. , Butti PO , Barras JP , et al: Red blood cell velocity in nailfold capillaries of men measured by a television microscope technique. Microvasc Res 7:61, 1974.

Tooke JE , Östergren I. , Fagrell B. : Synchronous assessment of human skin microcirculation by Laser-Doppler flowmetry and dynamic capillaroscopy. Int J Microcirc: Clin Exp 2:277, 1983.

10.

Halpern H. , Kuhn PH , Shaftel HE , et al: Raynaud's disease, Raynaud's phenomenon and serotonin. Angiology 11:151, 1960.

11.

Van Nueten JM , Janssen Paj , Van Beek J. , et al: Vascular effects of R 41 468, a novel antagonist of 5-HT serotonergic receptors. J Pharmacol Exp Ther 218:217, 1981.

12.

Tyml K. , Ellis CG : Evaluation of the flying spot technique as a television method for measuring red cell velocity in microvessels. Int J Microcirc: Clin Exp 1:145, 1982.

13.

Schmid-Schönbein H. , Volger E. , Teitel P. , et al: New hemorheological techniques for the routine laboratory. RACD II:27, 1981.

14.

Stranden F. , Roald OK , Krogh K. : Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist Ketanserin. Br Med J 285:1069, 1982.

15.

Seibold JR , Jagenau HM : Treatment of Raynaud's phenomenon with Ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor. Arthritis Rheum 27(2): 139, 1984.

16.

Van der Starre Pja , Scheijgrond HW , Reneman RS , et al: The use of Ketanserin, a 5-Hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery. Anesth Analg 62:63, 1983.

17.

Wenting GJ , Man in't Veld AJ , Woittiez AJ , et al: Treatment of hypertension with Ketanserin, a new 5-HT2 receptor antagonist. Br Med J 284:537, 1982.

18.

Clifford PC , Martin Mfr , Jene Sheddon F , et al: Treatment of vasospastic disease with prostaglandin F,. Br Med J 281:1031, 1980 .

19.

Rodeheffer RJ , Rommer JA , Wigley F. , et al: Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 308(15):880, 1983.